Propofol inhibits proliferation and epithelial-mesenchymal transition of MCF-7 cells by suppressing miR-21 expression
Source abstract
Abstract
Breast cancer is a common malignant tumor with a high incidence of recurrence and metastasis. It has been reported that propofol has certain anti-breast cancer effects, but the intrinsic molecular mechanism remains unclear. This study investigated the effect of propofol on breast cancer MCF-7 cells and its possible regulatory mechanisms. MCF-7 cells were treated by propofol, and then the effects of propofol on cell growth and epithelial-mesenchymal transition (EMT) were studied. We subsequently testified whether miR-21 was a downstream effector of propofol. As a result, propofol repressed the proliferation and migration of MCF-7 cells, but significantly induced apoptosis. Meanwhile, miR-21 expression and EMT were inhibited by propofol stimulation. The effects of propofol on MCF-7 cells proliferation, apoptosis and EMT were all attenuated when miR-21 was overexpressed. Besides this, the activation of PI3K/AKT and Wnt3a/β-catenin pathways was reduced by propofol stimulation in a miR-21-depedent manner. In conclusion, propofol can inhibit the proliferation and EMT of MCF-7 cells by down-regulating miR-21 expression. Moreover, miR-21 can further regulate PI3K/AKT and Wnt/β-catenin pathways.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Cancer, Stress, Anesthesia, and Immune Response · Cancer Cells and Metastasis · Anesthesia and Neurotoxicity Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Anesthesiology, The Affiliated Hospital of Qingdao University
Emergency Department, The Affiliated Hospital of Qingdao University
References (32)
Show source-provided references
1. 10.1038/s41598-017-09499-110.1038/s41598-017-09499-1 ↗
2. 10.7812/TPP/14-24110.7812/TPP/14-241 ↗
3. 10.1016/j.cub.2009.10.03710.1016/j.cub.2009.10.037 ↗
4. 10.1016/j.arcmed.2015.06.00610.1016/j.arcmed.2015.06.006 ↗
5. 10.1034/j.1399-6576.2002.460903.x10.1034/j.1399-6576.2002.460903.x ↗
6. Liu Z, Zhang J, Hong G, et al. Propofol inhibits growth and invasion of pancreatic cancer cells through regulation of the miR-21/Slug signaling pathway. Am J Transl Res. 2016;8:4120.
7. 10.1096/fj.14-26032310.1096/fj.14-260323 ↗
8. 10.1016/j.biopha.2011.10.00610.1016/j.biopha.2011.10.006 ↗
9. 10.1161/CIRCRESAHA.108.18877110.1161/CIRCRESAHA.108.188771 ↗
10. 10.1161/CIRCRESAHA.111.24745210.1161/CIRCRESAHA.111.247452 ↗
11. 10.1002/ddr.2125710.1002/ddr.21257 ↗
12. 10.1016/j.omtn.2018.09.01010.1016/j.omtn.2018.09.010 ↗
13. 10.1016/j.jep.2009.08.01410.1016/j.jep.2009.08.014 ↗
14. 10.1006/meth.2001.126210.1006/meth.2001.1262 ↗
15. Shan S, Lv Q, Zhao Y, et al. Wnt/β-catenin pathway is required for epithelial to mesenchymal transition in CXCL12 over expressed breast cancer cells. Int J Clin Exp Pathol. 2015;8:12357–12367.
16. 10.1517/14728222.2014.93805110.1517/14728222.2014.938051 ↗
17. 10.1093/carcin/bgs38310.1093/carcin/bgs383 ↗
18. Bodnar J. A review of agents for palliative sedation/continuous deep sedation: pharmacology and practical applications. Hospice J. 2017;31:16–37.
19. 10.1177/088307381666145810.1177/0883073816661458 ↗
20. 10.1213/ANE.000000000000150410.1213/ANE.0000000000001504 ↗
21. 10.1007/s13277-014-1677-710.1007/s13277-014-1677-7 ↗
22. Wang P, Chen J, Mu LH, et al. Propofol inhibits invasion and enhances paclitaxel- induced apoptosis in ovarian cancer cells through the suppression of the transcription factor slug. Eur Rev Med Pharmacol Sci. 2013;17:1722–1729.
23. 10.1016/j.bbrc.2015.10.12910.1016/j.bbrc.2015.10.129 ↗
24. 10.1111/anae.1333110.1111/anae.13331 ↗
25. 10.1161/01.ATV.15.5.62910.1161/01.ATV.15.5.629 ↗
26. 10.1111/nep.1315510.1111/nep.13155 ↗
27. 10.1016/j.ecoenv.2017.07.07310.1016/j.ecoenv.2017.07.073 ↗
28. 10.1177/204748731772711310.1177/2047487317727113 ↗
29. 10.1124/mol.117.11065010.1124/mol.117.110650 ↗
30. 10.1007/s11154-006-9003-310.1007/s11154-006-9003-3 ↗
31. 10.1101/cshperspect.a00805210.1101/cshperspect.a008052 ↗
32. 10.1159/00048883110.1159/000488831 ↗